To compared pregnancy outcome (Serum vitamin D level in mother and infant , preeclampsia rate, preterm birth rate, Infant birth weight, Infant length , APGAR score) between pregnant women who were given vitamin D supplementation and pregnant women who were given placebo
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
60
Vitamin D2 20000IU 1 tab oral weekly
Placebo drugs 1 tab oral weekly
Rajavithi hospital
Bangkok, Thailand
Serum 25-OH vitamin D level in pregnant women
measure in nmol/L
Time frame: At delivery time
Serum 25-OH vitamin D level in umbilicalcord blood
measure in nmol/L
Time frame: At delivery time
Preeclampsia
Measure by clinical and laboratory of preeclampsia ้high blood pressure ( \>= 140/90 mmHg) with proteinuria (UPCI \> 0.3 mg/dL or Urine protein 24 hours \> 300 mg) or in absence of proteinuria with new onset of any of the following * thrombocytopenia : Platelet count less than 100,000 x 10\^9 /L * Serum creatinine \> 1.1 mg/dL or doubling of the serum creatinine * Elevated liver transaminases to twice normal * Pulmonary edema * New onset headache unresponsive to medication * Visual symptom
Time frame: During pregnancy until delivery
Preterm birth
Delivery before GA 37 weeks
Time frame: At delivery time
Infant APGAR score
Measure at delivery time score 10/10 Appearance : Cyanotic, pale all over = 0 , Peripheral cyanotic only = 1 , Pink = 2 Pulse : 0 bpm = 0 , \<100 = 1, 100-140 = 2 Grimace : no response to stimulation = 0 , Grimace(facial movement ,weak cry) = 1 Cry when stimulated = 2 Activity (tone) : floppy = 0 , Some flexion = 1 , Well flexed and resisting extension = 2 Respiration : Apnoeic = 0 , Slow irregular = 1 , Strong cry = 2
Time frame: At delivery time
Infant birth weight
measure in kilograms
Time frame: At delivery time
Infant length
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
measure in centimeters
Time frame: At delivery time